Evaluation of the Effects of Oxygen Therapy and Enalapril for Diabetic Macular Ischemia
Recruitment status was: Recruiting
In this study, patients were divided into 3 group with 35 cases including: 1.oxygen 2.enalapril 3.control.
In the beginning of the study, best corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), and optical coherence tomography (OCT) were measured. Patients in the oxygen group were given oxygen 10 lit/min 1 hour twice a day at the first month, once a day at the second month and every other day at the third month. In the enalapril group, patients were given enalapril 5 mg every night and placebo was given for the patients in third group. At the end of first month the patients' vision was checked again and at the the end of the third month the first physical examinations were performed. In the first group, arterial blood gas (ABG) was taken before and after oxygen therapy as well.
|Diabetic Macular Ischemia||Drug: enalapril Other: oxygen Drug: placebo||Phase 1|
|Official Title:||Evaluation of the Effects of Oxygen Therapy and Enalapril for Diabetic Macular Ischemia|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00899587
|Contact: Masoud Soheilian, MDfirstname.lastname@example.org|
|Iran, Islamic Republic of|
|Ophthalmic Research Center||Recruiting|
|Tehran, Iran, Islamic Republic of, 166666|
|Contact: Masoud Soheilian, MD +98 21 22585952 email@example.com|